[Viva] Fwd: CATIE - TreatmentUpdate 184

Wed Jul 13 11:06:27 PDT 2011

---------- Forwarded message ----------
From: <mailing at mercury.catie.ca>
Date: Wed, Jul 13, 2011 at 10:46 AM
Subject: CATIE - TreatmentUpdate 184
To: dbecker106 at gmail.com

Dear Friend of CATIE and *TreatmentUpdate* subscriber,

I’m happy to share with you issue 184 of <http://www.catie.ca/tu.nsf>*
TreatmentUpdate <http://www.catie.ca/tu.nsf>,* as well as information about
our tenth anniversary issue of *The Positive Side*, tell you about a series
of free webinars on new HIV prevention technologies (NPTs), and provide you
with the latest updates from CATIE.

In this issue of *TreatmentUpdate*, Sean Hosein, our Science and Medicine
Editor, discusses gene therapy for HIV infection, compares efavirenz to
raltegravir, discusses bone health in the context of anti-HIV therapy, and
reviews a study on survival among some Aboriginal people who used HAART.

Highlights include:

   - Using gene therapy to help T-cells block HIV
   - A comparison between anti-HIV agents efavirenz and raltegravir
   - Overview of long-term anti-HIV therapy and the effects on bone health
   - Making sense of changes in bone density
   - Review of study that found reduced survival among some Aboriginal
   people who used HAART compared to non-Aboriginal people.

*Your opinion matters to us*

As a subscriber to *TreatmentUpdate*, we want your opinion on how we could
improve this publication. Please take 15 minutes to fill out our
online *Treatment
Update survey <http://www.surveymonkey.com/s/TreatmentUpdate>* and give us
your suggestions. We appreciate your feedback!

*The Positive Side turns 10! <http://www.positiveside.ca/e/V13I1/Toc_e.htm>*

In this special 10-year anniversary issue, we catch up with the HIV-positive
people who have appeared on the cover. Their stories are varied and
surprising. We also turn to life with HIV outside of Canada’s largest
cities, while other articles look at bone health and vaginal health. We tell
you about programs for HIV-positive families and feature the beautiful bead
work of Vancouver-based Aboriginal artist Ron Horsefall.

*Summer webinars explain new HIV prevention
technologies<http://www.catie.ca/eng/GetInvolved/webinarseries.shtml>
*

Frontline service providers and all those interested in understanding the
new HIV prevention technologies (NPTs) and their implications have a series
of free webinars to choose from, in both English and French, this July and
August:

   - Webinar 1: New HIV prevention technologies – The basics and the state
   of science: July 12 & 13

   - Webinar 2: Preparing for NPTs – Learning from the past and preparing
   for the future: July 27 & 28

   - Webinar 3: Can we prevent infection with HIV after an exposure? – The
   world of post-exposure prophylaxis: August 3 & 4

   - Webinar 4: Preparing for pre-exposure prophylaxis to prevent HIV
   infection: August 10 & 11

   - Webinar 5: Are people living with HIV less likely to pass HIV to others
   if they are on treatment? – Exploring the use of ‘treatment as prevention’:
   August 24 & 25

*Choose as many as you wish – but register early because space is limited! *To
register, contact James Wilton at CATIE (jwilton at catie.ca). For more
information, please visit our online Webinar
Series<http://www.catie.ca/eng/GetInvolved/webinarseries.shtml>page.
The webinars are presented by CATIE, the Interagency Coalition on AIDS and
Development (ICAD), the Canadian AIDS Society (CAS), and the Canadian Public
Health Association (CPHA).

*New HIV Prevention Technologies reports*

To learn more about new HIV prevention technologies (NPTs), read the
following two literature reviews, available to download at www.catie.ca:

   - *Sociobehavioral Issues of New Prevention
Technologies*<http://www2.catie.ca/sites/default/files/pdf/NPT%20sociobehavioral_EN.pdf>presents
a review of the literature on five biomedical approaches to HIV
   prevention: post-exposure prophylaxis, pre-exposure prophylaxis, treatment
   as prevention, microbicides and vaccines, with a focus on the
   socio-behavioural issues involved with these technologies

   - *Partial Efficacy and the Uptake of New Prevention
Technologies*<http://www.catie.ca/pdf/NPTPartialEfficacy-EN.pdf>looks
at how new HIV prevention technologies will likely offer only partial
   protection from HIV. This raises two questions: How should their use be
   promoted? and What is the best way to communicate the idea of partial
   protection while emphasizing the continued need to use established
   strategies?

*CATIE has entered the realm of Social Media! *

CATIE is also happy to announce its new presence on *Facebook *and *Twitter*!
Please visit our Facebook Fan Page
CATIEInfo<http://www.facebook.com/CATIEInfo>and follow us on Twitter
(@CATIEInfo <http://twitter.com/#!/CATIEInfo>) to connect with us and find
out what’s new and exciting at CATIE! We want to hear from you, and let you
know of all the new resources as they become available, inform you of the
events we attended, and so much more.

<http://www.facebook.com/CATIEInfo>    <http://twitter.com/#!/CATIEInfo>

As always, we encourage you to spread the word about CATIE, *TreatmentUpdate
* and other resources available through the CATIE Ordering Centre
<http://orders.catie.ca/index.php?language=en?id=TU181>and the CATIE
website<http://www.catie.ca/eng/home.shtml?id=TU181>
.

Sincerely,

Laurie Edmiston
Executive Director

========================================
TreatmentUpdate Subscription Information
========================================

TreatmentUpdate is a moderated mailing list operated by CATIE (the Canadian
AIDS Treatment Information Exchange) to distribute information about HIV,
AIDS and related infections in Canada.

To subscribe to the list, visit
http://orders.catie.ca/subscription/subscribe.shtml.

To cancel your subscription to the list, visit
http://orders.catie.ca/subscription/unsubscribe_tu.shtml.

For assistance with your subscription from a real human being, please send a
message to web at catie.ca.

TreatmentUpdate is written by Sean Hosein, with the collaboration of other
members of CATIE, in Toronto. Your comments are welcome.

Permission to Reproduce:

This document is copyrighted by CATIE (the Canadian AIDS Treatment
Information Exchange). All CATIE materials may be reprinted and/or
distributed without prior permission. However, reprints may not be edited
and must include the following text:

"From CATIE (the Canadian AIDS Treatment Information Exchange). For more
information, visit CATIE's Information Network at www.catie.ca."

For permission to edit any CATIE material for further publication, please
send an e-mail to info at catie.ca.

Decisions about particular medical treatments should always be made in
consultation with a qualified medical practitioner who is knowledgeable
about HIV-related illness and the treatments in question. More:
www.catie.ca/eng/Disclaimer.shtml.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.resist.ca/pipermail/viva/attachments/20110713/d7a3d679/attachment.html>